Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial

Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial

Abstract Background In the SafeBoosC-III trial, treatment guided by cerebral oximetry monitoring for the first 72 hours after birth did not reduce the incidence of death or severe brain injury in extremely preterm infants at 36 weeks’ postmenstrual age, as compared with usual care. Despite an associ...

Full description

Bibliographic Details
Main Authors: Marie Isabel Rasmussen, Mathias Lühr Hansen, Adelina Pellicer, Christian Gluud, Eugene Dempsey, Jonathan Mintzer, Simon Hyttel-Sørensen, Anne Marie Heuchan, Cornelia Hagmann, Ebru Ergenekon, Gabriel Dimitriou, Gerhard Pichler, Gunnar Naulaers, Guoqiang Cheng, Jakub Tkaczyk, Hans Fuchs, Monica Fumagalli, Saudamini Nesargi, Siv Fredly, Tomasz Szczapa, Anne Mette Plomgaard, Bo Mølholm Hansen, Janus Christian Jakobsen, Gorm Greisen
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Trials
Subjects:
Randomised clinical trial
Preterm
Near-infrared spectroscopy
Protocol
Follow-up
Neurodevelopment
Online Access:https://doi.org/10.1186/s13063-023-07653-x

Internet

https://doi.org/10.1186/s13063-023-07653-x

Similar Items